Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00108-020-00834-9 http://scihub22266oqcxt.onion/10.1007/s00108-020-00834-9 32548652!7296906!32548652     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Internist+(Berl) 2020 ; 61 (8): 782-788 Nephropedia Template TP {{tp|p=32548652|t=2020. Epidemiologie von SARS-CoV-2-Infektion und COVID-19 |pdf=|usr=}}{{32548652}} gab.com Text Epidemiologie von SARS-CoV-2-Infektion und COVID-19 JO: Internist (Berl) http://www.kidney.de/pget.php?&tw=1&pmid=32548652 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta?Coronavirus that was first detected in 2019 in Wuhan, China. In the ensuing months it has been transmitted worldwide. Here the authors present the current knowledge on the epidemiology of this virus. SARS-CoV?2 replicates mainly in the upper and lower respiratory tract and is primarily transmitted by droplets from asymptomatic and symptomatic infected subjects. The estimate for the basic reproduction number (R) is currently between 2 and 3, while the incubation period is 6 (median, range 2-14) days. Although most infections are uncomplicated, 5-10% of cases develop pneumonia, which can lead to hospitalization, respiratory failure and multiorgan failure. Risk factors for a complicated disease course include age, hypertension, chronic cardiovascular and pulmonary disease and immunodeficiency. The overall case fatality rate is 1.4%, with the rate rising in the sixth decade of life. Nosocomial and infections in medical personnel have been reported. Drastic reductions in social contact have been implemented in many countries with outbreaks of SARS-CoV?2, leading to rapid reductions in R. Which of the measures have been effective is still unknown. Twit Text FOAVip Epidemiologie von SARS-CoV-2-Infektion und COVID-19 ????Internist (Berl) http://www.kidney.de/pget.php?&tw=1&pmid=32548652 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32548652 #FOAvip English Wikipedia <ref>{{Cite pmid|32548652}}</ref> Epidemiologie von SARS-CoV-2-Infektion und COVID-19 #MMPMID32548652 Salzberger B; Buder F; Lampl B; Ehrenstein B; Hitzenbichler F; Hanses F Internist (Berl) 2020[Aug]; 61 (8): 782-788 PMID32548652show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta?Coronavirus that was first detected in 2019 in Wuhan, China. In the ensuing months it has been transmitted worldwide. Here the authors present the current knowledge on the epidemiology of this virus. SARS-CoV?2 replicates mainly in the upper and lower respiratory tract and is primarily transmitted by droplets from asymptomatic and symptomatic infected subjects. The estimate for the basic reproduction number (R) is currently between 2 and 3, while the incubation period is 6 (median, range 2-14) days. Although most infections are uncomplicated, 5-10% of cases develop pneumonia, which can lead to hospitalization, respiratory failure and multiorgan failure. Risk factors for a complicated disease course include age, hypertension, chronic cardiovascular and pulmonary disease and immunodeficiency. The overall case fatality rate is 1.4%, with the rate rising in the sixth decade of life. Nosocomial and infections in medical personnel have been reported. Drastic reductions in social contact have been implemented in many countries with outbreaks of SARS-CoV?2, leading to rapid reductions in R. Which of the measures have been effective is still unknown. |Basic Reproduction Number[MESH] |Betacoronavirus/physiology[MESH] |COVID-19[MESH] |China[MESH] |Communicable Disease Control[MESH] |Coronavirus Infections/*epidemiology/mortality/prevention & control[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*epidemiology/mortality/prevention & control[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]Epidemiologie von SARS-CoV-2-Infektion und COVID-19 (epmc).pdf DeepDyve Pubget Overpricing